ASSOCIATION BETWEEN ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITION, CARDIOVASCULAR BIOMARKERS AND CARDIAC REMODELING IN HEART FAILURE WITH REDUCED EJECTION FRACTION

Authors :: Kristin M Williamson
James L. Januzzi
Ritvik R Kandanelly
Alexander Camacho
Sean P. Murphy
Jonathan H Ward
Javed Butler
Scott D. Solomon
Ileana L. Piña
Alan S. Maisel
G. Michael Felker
Margaret F. Prescott
Source :: Journal of the American College of Cardiology. 77:610
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.
Abstract: Background: Sacubitril/valsartan (S/V) treatment is associated with reverse cardiac remodeling and reductions in biomarkers reflecting ventricular wall stress and myocardial injury, such as NT-proB...

Subjects :: medicine.medical_specialty
Angiotensin receptor
Ejection fraction
business.industry
Cardiovascular biomarkers
Ventricular wall
medicine.disease
Sacubitril
Valsartan
Internal medicine
Heart failure
cardiovascular system
Cardiology
Medicine
Cardiology and Cardiovascular Medicine
business
Neprilysin
medicine.drug

Tools